Current Psychiatry Research and Reviews
Title:Rethinking Depression
Volume: 15 Issue: 1
Author(s): Yong-Ku Kim
Affiliation:
Export Options
About this article
Cite this article as:
Kim Yong-Ku , Rethinking Depression, Current Psychiatry Research and Reviews 2019; 15 (1) . https://dx.doi.org/10.2174/266608221501190416112800
DOI https://dx.doi.org/10.2174/266608221501190416112800 |
Print ISSN 2666-0822 |
Publisher Name Bentham Science Publisher |
Online ISSN 2666-0830 |
Call for Papers in Thematic Issues
Stress, anxiety and mental Health Assessment Using Artificial Intelligence
COVID-19 has greatly impacted the mental lives of people of all ages across the world. People whether infected with COVID or not have exhibited stress and anxiety and this has impacted their day-to-day lives. Increased digitalization, job pressures, health issues, and other factors have led to stress and mental issues. ...read more
The Power of Integration:Interactive Design and Bioengineering Shaping the Future of Autism Intervention
Over the next few years, what developments can be expected in the intersection of interactive technology with bioengineering-based interventions for autism and neuroscientific research? The field of interactive design has seen remarkable advancements, establishing robust methods that aid in autism education and enhance quality of life. Simultaneously, various computer-assisted methods ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Urotensin II: A Vascular Mediator in Health and Disease
Current Vascular Pharmacology Vitiligo: Pathogenetic Hypotheses and Targets for Current Therapies
Current Drug Metabolism Always Around, Never the Same: Pathways of Amyloid Beta Induced Neurodegeneration Throughout the Pathogenic Cascade of Alzheimers Disease
Current Medicinal Chemistry Pharmacological Properties of Glutamatergic Drugs Targeting NMDA Receptors and their Application in Major Depression
Current Pharmaceutical Design Role of Nitric Oxide in Patients with Schizophrenia- a Systematic Review of the Literature
Current Psychiatry Reviews Neuroinflammation in Alzheimer’s Disease: Microglia, Molecular Participants and Therapeutic Choices
Current Alzheimer Research Spectroscopic and Chromatographic Characterization of Crude Natural Shilajit from Himachal Pradesh, India
The Natural Products Journal Therapeutic Targeting of TRPV1 by Resiniferatoxin, from Preclinical Studies to Clinical Trials
Current Topics in Medicinal Chemistry DNMT3B Promoter Polymorphisms and Risk of Late Onset Alzheimer’s Disease
Current Alzheimer Research Methylone and Monoamine Transporters: Correlation with Toxicity
Current Neuropharmacology The Long Run: Neuroprotective Effects of Physical Exercise on Adult Neurogenesis from Youth to Old Age
Current Neuropharmacology GABA and Neuroactive Steroid Interactions in Glia: New Roles for Old Players?
Current Neuropharmacology Targeted Blood-to-Brain Drug Delivery – 10 Key Development Criteria
Current Pharmaceutical Biotechnology Tumor Necrosis Factor Blockade for Treatment of Inflammatory Bowel Disease: Efficacy and Safety
Current Molecular Pharmacology Pharmacokinetic and Pharmacodynamic Variability: A Daunting Challenge in Drug Therapy
Current Drug Metabolism Marijuana and Adolescents: Treatment Strategies for Clinicians
Adolescent Psychiatry Discovery of New Medication for the Treatment of Depression Comorbid with Inflammatory Diseases
Current Topics in Medicinal Chemistry New Perspectives in the Treatment of Cushings Syndrome
Current Drug Targets - Immune, Endocrine & Metabolic Disorders EDITORIAL [Hot Topic: Transthyretin: A Small Protein in the Big World of Amyloidoses (Guest Editors: Adriano Martinelli and Gabriella Ortore)]
Current Medicinal Chemistry Recent Advances in the Treatment of Neurogenic Erectile Dysfunction
Recent Patents on CNS Drug Discovery (Discontinued)